Cardio Diagnostics Holdings, Inc. current report, 18 September 2026

Cardio Diagnostics Holdings, Inc. (CDIO) - Form 8-K Summary

Business Context and Reporting Period

This Form 8-K, dated September 18, 2026, reports the results of the Annual Meeting of Stockholders held on the same date. The Company is a Delaware corporation with its principal executive offices in Chicago, IL. The filing details the voting outcomes for three specific proposals submitted to shareholders.

Key Financial Metrics

This filing is a current report regarding corporate governance and shareholder voting. It does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The filing text does not provide a clear value for any financial indicators.

Material Changes and Voting Results

The Annual Meeting saw approximately 60.25% of eligible shares (1,783,220 of 2,959,469) in attendance or represented by proxy. All three proposals were approved:

  • Proposal 1 (Election of Directors): Seven directors were elected on a plurality basis. Significant broker non-votes (625,505) were recorded for all nominees.
  • Proposal 2 (Share Issuance): Shareholders approved the future issuance of shares or convertible securities equal to 20% or more of outstanding common stock in non-public transactions, as required by Nasdaq Rule 5635(d). Votes: 936,488 For, 193,532 Against, 27,695 Abstain.
  • Proposal 3 (Auditor Ratification): The appointment of Prager Metis CPA's LLC as the independent registered public accounting firm for the fiscal year ending December 31, 2026, was ratified. Votes: 1,722,311 For, 57,874 Against, 3,035 Abstain.

Guidance, Outlook, and Risks

The filing contains no management commentary, financial guidance, or outlook for future periods. No specific risks or contingencies are disclosed in this document, other than the standard governance matters addressed by the shareholder vote.

Key Facts for Investor Verification

  • Verify the specific terms and potential dilution impact of the approved 20% share issuance authority (Proposal 2) in the definitive proxy statement filed on August 5, 2026.
  • Confirm the engagement letter and audit scope with the newly ratified auditor, Prager Metis CPA's LLC.
  • Note the high volume of broker non-votes (625,505) on the director election, which may indicate institutional holders did not receive voting instructions for this matter.
  • Review the Company's most recent 10-K or 10-Q for actual financial performance data, as this 8-K contains none.